Discovery of the first non-ATP competitive IGF-1R kinase inhibitors: Advantages in comparison with competitive inhibitors

Bioorganic & Medicinal Chemistry Letters
2011.0

Abstract

A new series of IGF-1R inhibitors related to hydantoins were identified from a lead originating from HTS. Their noncompetitive property as well as their slow binding characteristics provided a series of compounds with unique selectivity and excellent cellular activities.

Knowledge Graph

Similar Paper

Discovery of the first non-ATP competitive IGF-1R kinase inhibitors: Advantages in comparison with competitive inhibitors
Bioorganic & Medicinal Chemistry Letters 2011.0
Discovery and selectivity-profiling of 4-benzylamino 1-aza-9-oxafluorene derivatives as lead structures for IGF-1R inhibitors
Bioorganic & Medicinal Chemistry Letters 2010.0
Design of Selective, ATP-Competitive Inhibitors of Akt
Journal of Medicinal Chemistry 2010.0
5-Benzylidene-hydantoins as new EGFR inhibitors with antiproliferative activity
Bioorganic & Medicinal Chemistry Letters 2006.0
Identification of a Water-Soluble Indirubin Derivative as Potent Inhibitor of Insulin-like Growth Factor 1 Receptor through Structural Modification of the Parent Natural Molecule
Journal of Medicinal Chemistry 2017.0
Dianilinophthalimides: Potent and Selective, ATP-Competitive Inhibitors of the EGF-Receptor Protein Tyrosine Kinase
Journal of Medicinal Chemistry 1994.0
<sup>19</sup>F-NMR-Based Dual-Site Reporter Assay for the Discovery and Distinction of Catalytic and Allosteric Kinase Inhibitors
ACS Medicinal Chemistry Letters 2017.0
Synthesis and Biological Testing of Purine Derivatives as Potential ATP-Competitive Kinase Inhibitors
Journal of Medicinal Chemistry 2005.0
Discovery and anti-inflammatory evaluation of benzothiazepinones (BTZs) as novel non-ATP competitive inhibitors of glycogen synthase kinase-3β (GSK-3β)
Bioorganic &amp; Medicinal Chemistry 2018.0
Discovery of selective irreversible inhibitors for EGFR-T790M
Bioorganic &amp; Medicinal Chemistry Letters 2011.0